Literature DB >> 21943973

What is the pathophysiology of a hormone-resistant prostate tumour?

Bertrand Tombal1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21943973     DOI： 10.1016/S0959-8049(11)70163-0

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0959-8049            Impact factor:   9.162


× No keyword cloud information.
  9 in total

1.  TGF-β1 mediates the radiation response of prostate cancer.

Authors:  Chun-Te Wu; Ching-Chuan Hsieh; Tzu-Chen Yen; Wen-Cheng Chen; Miao-Fen Chen
Journal:  J Mol Med (Berl)       Date:  2014-09-18       Impact factor: 4.599

2.  Efficacy, quality of life, and safety of cabazitaxel in Canadian metastatic castration-resistant prostate cancer patients treated or not with prior abiraterone.

Authors:  Fred Saad; Eric Winquist; Stacey Hubay; Scott Berry; Hazem Assi; Eric Levesque; Nathalie Aucoin; Piotr Czaykowski; Jean-Baptiste Lattouf; Karine Alloul; John Stewart; Srikala S Sridhar
Journal:  Can Urol Assoc J       Date:  2016 Mar-Apr       Impact factor: 1.862

3.  Post genome-wide association studies functional characterization of prostate cancer risk loci.

Authors:  Junfeng Jiang; Weirong Cui; Wanwipa Vongsangnak; Guang Hu; Bairong Shen
Journal:  BMC Genomics       Date:  2013-12-09       Impact factor: 3.969

Review 4.  Androgen receptors beyond prostate cancer: an old marker as a new target.

Authors:  Javier Munoz; Jennifer J Wheler; Razelle Kurzrock
Journal:  Oncotarget       Date:  2015-01-20

Review 5.  Understanding prostate-specific antigen dynamics in monitoring metastatic castration-resistant prostate cancer: implications for clinical practice.

Authors:  Atsushi Mizokami; Kouji Izumi; Hiroyuki Konaka; Yasuhide Kitagawa; Yoshifumi Kadono; Kazutaka Narimoto; Takahiro Nohara; Amit K Bahl; Mikio Namiki
Journal:  Asian J Androl       Date:  2017 Mar-Apr       Impact factor: 3.285

Review 6.  The effect of additional chemotherapy on high-risk prostate cancer: a systematic review and meta-analysis.

Authors:  Junru Chen; Xingming Zhang; Guangxi Sun; Jinge Zhao; Jiandong Liu; Peng Zhao; Jindong Dai; Pengfei Shen; Hao Zeng
Journal:  Onco Targets Ther       Date:  2018-12-13       Impact factor: 4.147

7.  Loss of Fibroblast-Dependent Androgen Receptor Activation in Prostate Cancer Cells is Involved in the Mechanism of Acquired Resistance to Castration.

Authors:  Kenichiro Ishii; Izumi Matsuoka; Takeshi Sasaki; Kohei Nishikawa; Hideki Kanda; Hiroshi Imai; Yoshifumi Hirokawa; Kazuhiro Iguchi; Kiminobu Arima; Yoshiki Sugimura
Journal:  J Clin Med       Date:  2019-09-03       Impact factor: 4.241

8.  Comprehensive genomics in androgen receptor-dependent castration-resistant prostate cancer identifies an adaptation pathway mediated by opioid receptor kappa 1.

Authors:  Yuki Makino; Yuki Kamiyama; J B Brown; Toshiya Tanaka; Ryusuke Murakami; Yuki Teramoto; Takayuki Goto; Shusuke Akamatsu; Naoki Terada; Takahiro Inoue; Tatsuhiko Kodama; Osamu Ogawa; Takashi Kobayashi
Journal:  Commun Biol       Date:  2022-04-01

Review 9.  Adaptive responses of androgen receptor signaling in castration-resistant prostate cancer.

Authors:  Sven Perner; Marcus V Cronauer; Andres Jan Schrader; Helmut Klocker; Zoran Culig; Aria Baniahmad
Journal:  Oncotarget       Date:  2015-11-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.